GeneBioTech Ltd Full Year 2023 Earnings EPS 301 - Simply Wall St

086060 Stock  KRW 3,410  5.00  0.15%   
About 61% of GeneBioTech's investor base is looking to short. The analysis of current outlook of investing in GeneBioTech Co suggests that many traders are alarmed regarding GeneBioTech's prospects. The current market sentiment, together with GeneBioTech's historical and current headlines, can help investors time the market. In addition, many technical investors use GeneBioTech stock news signals to limit their universe of possible portfolio assets.
  
GeneBioTech Ltd Full Year 2023 Earnings EPS 301 Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

GeneBioTech Fundamental Analysis

We analyze GeneBioTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneBioTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneBioTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

GeneBioTech is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

GeneBioTech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeneBioTech stock to make a market-neutral strategy. Peer analysis of GeneBioTech could also be used in its relative valuation, which is a method of valuing GeneBioTech by comparing valuation metrics with similar companies.

Complementary Tools for GeneBioTech Stock analysis

When running GeneBioTech's price analysis, check to measure GeneBioTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneBioTech is operating at the current time. Most of GeneBioTech's value examination focuses on studying past and present price action to predict the probability of GeneBioTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneBioTech's price. Additionally, you may evaluate how the addition of GeneBioTech to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bonds Directory
Find actively traded corporate debentures issued by US companies